MedPath

Clovirasi

Brand Name: Clovirasi

Generic Name: Acyclovir (as sodium)

Active
Registration Number

DRP-15539

Dosage Form

Powder for Injection

Issuance Date

July 31, 2024

Expiry Date

July 31, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength250 mg
PackagingUSP Type III Flint Glass Vial with Grey Bromobutyl Rubber Stopper and Flip-off Seal x 10 mL (Box 1's)

Classification

C
Classification
Prescription (Rx) Drug
P
Pharmacologic
Antiviral
A
Application
Initial (Rx)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Acyclovir (as sodium)Active
Monograph: acyclovir (as sodium)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform